These findings demonstrate that targeted aza-substitution yields a protease-stable, biologically active GLP-1RA with metabolic benefits, establishing azapeptides as a promising scaffold for next-generation incretin-based therapies in diabetes and obesity
3.2.3 Inflammatory mediator release Astrocytes, when stimulated by epileptiform activity (e.g., repeated depolarization or IL-1), secrete various inflammatory mediators such as IL-6, TNF-, and CCL2
Medically Supervised Our programs are designed by doctors and nutritionists with decades of experience helping people lose weight
The contents of this website, including text, graphics, images and any other material are intended for informational and educational purposes only and are not intended to substitute for professional medical advice, diagnosis or treatment